Abstract:Objective: To observe the clinical therapeutic efficacy,disease severity and adverse reactions of electroacupuncture on mild or moderate depression combining with Paroxetine and the effect of electroacupuncture on the side-effects of Paroxetine treatment for depression.Methods: Fifty-five patients with mild or moderate depression were randomly divided into group A(Paroxetine group,29 patients)and group B(Electroacupuncture combining with Paroxetine group,26 patients).The therapeutic period for the two groups was 6 weeks.Hamilton Depression Rating Scale for Depression(HAMD),Rating Scale for Side Effects(SERS) and Clinical Global Impression Tables(CGI) were used to evaluate the efficacy before the research and after treatment on 1 week,2 weeks,4 weeks,6 weeks.Results: After two weeks' treatment,HAMD scores of group A were significant different compared with the beginning of the research(P<0.05);HAMD scores of group B after one-week's treatment were significant different compared with the beginning of the research(P<0.05);After six weeks,treatment,there were no sigficiant differences between group A and group B.Total effective rate of HAMD for group A was 71.4%,Total effective rate of HAMD for group B was 88%;Total effective rate of HAMD was significantly different between the two groups(P<0.05).SERS scores for group A was no different compared with the beginning of the research.SERS scores for group B were different compared with the beginning of the research for the fourth week(P<0.05).After 6 weeks' treatment,CGI scores were significant differences between group A and group B in disease severity,efficacy comments and efficacy index(P<0.05).The Evaluation resluts of CGI showed that the illness severity,assessment of efficacy and therapeuticindex between two groups all had significant differences(P<0.05).Conclusions: Electroacupuncture could improve Paroxetine efficacy on mild or moderate depression.At the same time,electroacupuncture combining with Paroxetine could significantly decrease the side-effects of Paroxetine.

Efficacy and safety of enteric-coted sustained release tablets in the treatment of major depression

The efficacy and safety of venlafaxine XR in treating patients with major depression in a multicenter,open-label, 16 week study

Efficacy and Safety of Quetiapine Extended Release Monotherapy in Bipolar Depression: a Multi-Center, Randomized, Double-Blind, Placebo-Controlled Trial

Randomized,multicenter,double blind comparative trial of reboxetine in the treatment of depression with or without anxiety

Duloxetine Versus Paroxetine in the Treatment of Major Depressive Disorder: a Randomized Double-Blind Multicentre Controlled Study

Treatment of Major Depressive Disorders with Generic Duloxetine and Paroxetine: a Multi-Centered, Double-Blind, Double-Dummy, Randomized Controlled Clinical Trial.

Treatment with Bupropion Sustained Release Tablet in Patients with Depression:A Randomized,double-Blind,multi-center Clinical Trial

A comparative study of domestic and imported proucts of paroxetine on efficacy and safety in patients with major depression

Bupropion-sustained release in treatment of depression (72 patients) : a randomized, double-blind, doubledummy, multi-center clinical trial

Multi-center,randomized,and double-blind controlled clinical trial of duloxetine enteric capsule in treatment of depression

The effect evaluation of electroacupuncture improving therapeutic effects and decreasing the side-effects of Paroxetine for mild or moderate depression patients

Efficacy and Safety of Bupropion Hydrochloride Extended-Release Versus Escitalopram Oxalate in Chinese Patients with Major Depressive Disorder: Results from a Randomized, Double-Blind, Non-Inferiority Trial.

Efficacy and Safety of Morinda Officinalis Oligose Capsule in the Treatment of Mild or Moderate Depression

The Efficacy and Safety of Citalopram in Treatment of Depression: a Multi-Center, Open-Label Study

Fluoxetine Enteric Tablet Versus Fluoxetine in Continuation Treatment of Major Depressive Disorder:A Multicentre Randomized Double-Blind Controlled Study

Study of Bupropion Hydrochloride Tablet and Fluoxetine in Treatment of Depression Multicenter Clinical Trial

Effect of Electroacupuncture on Therapeutic Effects and Onset Time of Paroxetine for Mild or Moderate Depression Patients

EFFECT OF PAROXETINE COMBINED WITH QUETIAPINE IN THE TREATMENT OF DEPRESSION WITH PHYSICAL SYMPTOMS

Efficacy and Safety of Escitalopram in Treatment of Severe Depression in Chinese Population.

A Randomized and Double-Blind Comparison with Reboxetine and Citalopram in Patients with Retardant Depressive Disorder

Citalopram in the Treatment of Depressive Disorders: an Open Label, Multicenter Study in China